Rani Therapeutics Holdings (RANI) Long-Term Debt Issuances (2020 - 2022)
Rani Therapeutics Holdings' Long-Term Debt Issuances history spans 3 years, with the latest figure at $14.9 million for Q4 2022.
- On a quarterly basis, Long-Term Debt Issuances rose 966.45% to $14.9 million in Q4 2022 year-over-year; TTM through Dec 2023 was $29.6 million, a 0.0% change, with the full-year FY2022 number at $29.6 million, changed N/A from a year prior.
- Long-Term Debt Issuances came in at $14.9 million for Q4 2022, up from $14.7 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $14.9 million in Q4 2022, with the low at -$1.7 million in Q4 2021.
- Historically, Long-Term Debt Issuances has averaged $5.9 million across 3 years, with a median of $1.7 million in 2021.
- Biggest five-year swings in Long-Term Debt Issuances: crashed 1202.56% in 2021 and later surged 966.45% in 2022.
- Year by year, Long-Term Debt Issuances stood at $156000.0 in 2020, then tumbled by 1202.56% to -$1.7 million in 2021, then skyrocketed by 966.45% to $14.9 million in 2022.
- Business Quant data shows Long-Term Debt Issuances for RANI at $14.9 million in Q4 2022, $14.7 million in Q3 2022, and -$1.7 million in Q4 2021.